Shu‐Jin Li

985 total citations · 1 hit paper
22 papers, 742 citations indexed

About

Shu‐Jin Li is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Shu‐Jin Li has authored 22 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Oncology. Recurrent topics in Shu‐Jin Li's work include Immunotherapy and Immune Responses (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Shu‐Jin Li is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Shu‐Jin Li collaborates with scholars based in China, United States and Hong Kong. Shu‐Jin Li's co-authors include Zhi‐Jun Sun, Qi‐Chao Yang, Zhigang Xu, Shuo Wang, Tian Zhang, Yuejun Kang, Peng Xue, Xianbin Ma, An Song and Jianwei Sun and has published in prestigious journals such as Chemical Society Reviews, Advanced Materials and Nature Communications.

In The Last Decade

Shu‐Jin Li

22 papers receiving 735 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy

2023 143 citations Liang Zhang, An Song et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shu‐Jin Li China	13	316	290	139	133	121	22	742
Lingfei Han China	16	186 0.6×	267 0.9×	71 0.5×	91 0.7×	70 0.6×	30	574
Sadegh Dehghani Iran	15	367 1.2×	589 2.0×	60 0.4×	160 1.2×	159 1.3×	21	982
Zili Gu Netherlands	13	317 1.0×	252 0.9×	186 1.3×	99 0.7×	55 0.5×	18	617
Małgorzata Stec Poland	18	179 0.6×	223 0.8×	164 1.2×	259 1.9×	109 0.9×	48	818
Xinying Yu China	12	330 1.0×	157 0.5×	125 0.9×	51 0.4×	156 1.3×	18	572
Binfan Chen China	12	470 1.5×	340 1.2×	362 2.6×	209 1.6×	72 0.6×	14	913
Qi Meng China	10	391 1.2×	231 0.8×	118 0.8×	62 0.5×	177 1.5×	18	606
Samad Muhammadnejad Iran	15	133 0.4×	272 0.9×	98 0.7×	263 2.0×	66 0.5×	58	763
Xiaomin Yang China	17	144 0.5×	271 0.9×	88 0.6×	55 0.4×	115 1.0×	32	656
Diego A. Chiappetta Argentina	11	236 0.7×	436 1.5×	54 0.4×	108 0.8×	119 1.0×	17	1.1k

Countries citing papers authored by Shu‐Jin Li

Since Specialization

Citations

This map shows the geographic impact of Shu‐Jin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Jin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Jin Li more than expected).

Fields of papers citing papers by Shu‐Jin Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Jin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Jin Li. The network helps show where Shu‐Jin Li may publish in the future.

Co-authorship network of co-authors of Shu‐Jin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Jin Li. A scholar is included among the top collaborators of Shu‐Jin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Jin Li. Shu‐Jin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Hao, Mengjie Zhang, Boxin Zhang, et al.. (2025). Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4+ T cells in head and neck cancer. Nature Communications. 16(1). 4228–4228. 7 indexed citations

Qian, Da, et al.. (2025). Trends in the global, national, and regional burden of breast cancer among adolescents and young adults from 1990 to 2021: Analyses of the 2021 global burden of disease study. The Breast. 82. 104486–104486. 1 indexed citations

Tang, Hongchao, Danhong Wang, Da Qian, et al.. (2024). Xihuang pill suppresses breast cancer malignancy by inhibiting TGF-β signaling and acquires chemotherapy benefits. Journal of Ethnopharmacology. 337(Pt 3). 119000–119000. 4 indexed citations

Liu, Yuan‐Tong, Lei Chen, Shu‐Jin Li, et al.. (2024). Dysregulated Wnt/β-catenin signaling confers resistance to cuproptosis in cancer cells. Cell Death and Differentiation. 31(11). 1452–1466. 38 indexed citations

Li, Shu‐Jin, Feng Tian, Yuan‐Tong Liu, et al.. (2024). m1A inhibition fuels oncolytic virus-elicited antitumor immunity via downregulating MYC/PD-L1 signaling. International Journal of Oral Science. 16(1). 36–36. 16 indexed citations

Zhang, Liang, An Song, Qi‐Chao Yang, et al.. (2023). Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy. Nature Communications. 14(1). 5355–5355. 143 indexed citations breakdown →

Wang, Shengchun, Pengjie Wang, Shu‐Jin Li, et al.. (2023). Electrochemical flow aziridination of unactivated alkenes. National Science Review. 10(10). nwad187–nwad187. 9 indexed citations

Liu, Yuan‐Tong, Shu‐Jin Li, Shuo Wang, et al.. (2023). LIMP-2 enhances cancer stem-like cell properties by promoting autophagy-induced GSK3β degradation in head and neck squamous cell carcinoma. International Journal of Oral Science. 15(1). 24–24. 13 indexed citations

Liu, Shuyan, Shu‐Jin Li, Yaoqiang Du, et al.. (2023). Integrative landscape analysis of prognostic model biomarkers and immunogenomics of disulfidptosis-related genes in breast cancer based on LASSO and WGCNA analyses. Journal of Cancer Research and Clinical Oncology. 149(18). 16851–16867. 7 indexed citations

10.

Ma, Xianbin, Shu‐Jin Li, Tian Zhang, et al.. (2022). Bioengineered nanogels for cancer immunotherapy. Chemical Society Reviews. 51(12). 5136–5174. 144 indexed citations

11.

Zhou, Junjie, Xiaohong Li, Fuyu Qi, et al.. (2022). Implantable versatile oxidized bacterial cellulose membrane for postoperative HNSCC treatment via photothermal-boosted immunotherapy. Nano Research. 16(1). 951–963. 25 indexed citations

12.

Li, Shu‐Jin & Zhi‐Jun Sun. (2022). Fueling immune checkpoint blockade with oncolytic viruses: Current paradigms and challenges ahead. Cancer Letters. 550. 215937–215937. 17 indexed citations

13.

Su, Wen, Wei Qiu, Shu‐Jin Li, et al.. (2022). A Dual‐Responsive STAT3 Inhibitor Nanoprodrug Combined with Oncolytic Virus Elicits Synergistic Antitumor Immune Responses by Igniting Pyroptosis. Advanced Materials. 35(11). e2209379–e2209379. 87 indexed citations

14.

Li, Shu‐Jin, et al.. (2021). Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges. Cancer Communications. 41(9). 830–850. 54 indexed citations

15.

Li, Hao, et al.. (2021). CMTM4 regulates epithelial–mesenchymal transition and PD‐L1 expression in head and neck squamous cell carcinoma. Molecular Carcinogenesis. 60(8). 556–566. 17 indexed citations

16.

He, Zhihui, Chun‐Lan Xie, Lin Xu, et al.. (2021). Solitumergosterol A, a unique 6/6/6/6/5 steroid from the deep-sea-derived Penicillium solitum MCCC 3A00215. Organic & Biomolecular Chemistry. 19(43). 9369–9372. 15 indexed citations

17.

Li, Shu‐Jin, et al.. (2021). Gas and gas-generating nanoplatforms in cancer therapy. Journal of Materials Chemistry B. 9(41). 8541–8557. 51 indexed citations

18.

Lv, Diya, Yan Cao, Langdong Chen, et al.. (2018). Simulation Strategies for Characterizing Phosphodiesterase-5 Inhibitors in Botanical Dietary Supplements. Analytical Chemistry. 90(18). 10765–10770. 6 indexed citations

19.

Lv, Diya, Yan Cao, Ziyang Lou, et al.. (2014). Rapid on-site detection of ephedrine and its analogues used as adulterants in slimming dietary supplements by TLC-SERS. Analytical and Bioanalytical Chemistry. 407(5). 1313–1325. 65 indexed citations

20.

Gu, Zhenyong, et al.. (2003). [Effect of peroxynitrite on the reactivity of rabbit pulmonary arteries in vitro].. PubMed. 55(4). 469–74. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact